180 results
Page 4 of 9
8-K
EX-99.1
bxz 7jhbskaw8v
24 Feb 15
Nektar Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results
12:00am
8-K
upjquz
24 Feb 15
Nektar Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results
12:00am
8-K
EX-99.1
y267l2
26 Jan 15
Regulation FD Disclosure
12:00am
8-K
amae2o5cv xuy8z
13 Jan 15
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
5ghzdap 6wgwplhywyn
26 Feb 14
Nektar Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results
12:00am
8-K
EX-99.2
vjx m0j4stlcuwj
14 Jan 14
Other Events
12:00am
8-K
EX-99.1
yqns dzq9q1dv44me
14 Jan 14
Other Events
12:00am
8-K
EX-99.1
m87460js ppxgq
1 Oct 13
Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
12:00am
8-K
EX-99.1
tnuxz10ooi
26 Sep 13
Nektar Announces Preliminary Topline Results from Phase 2 Efficacy Study for NKTR-181 in Chronic Pain Patients with Osteoarthritis of the Knee
12:00am